Steffi Oesterreich Selected Research

Progesterone Receptors (Progesterone Receptor)

1/2021	Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer.
1/2018	Precision Medicine in Hormone Receptor-Positive Breast Cancer.
11/2016	Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer.
6/2011	Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.
6/2010	Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
4/2003	Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steffi Oesterreich Research Topics

Disease

112	Breast Neoplasms (Breast Cancer) 03/2024 - 04/2003
86	Neoplasms (Cancer) 03/2024 - 04/2003
17	Lobular Carcinoma 02/2024 - 06/2013
15	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2012
10	Carcinogenesis 05/2022 - 10/2006
6	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 12/2012
5	Triple Negative Breast Neoplasms 01/2023 - 06/2013
4	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2016
3	Ductal Carcinoma 11/2018 - 03/2014
2	Disease Progression 01/2021 - 12/2016
2	Dwarfism 03/2009 - 04/2005
1	Carcinoma (Carcinomatosis) 07/2023
1	Inflammation (Inflammations) 01/2022
1	Secretory breast carcinoma 01/2022
1	Malignant Pleural Effusion 01/2022
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2022
1	Pain (Aches) 08/2021
1	Spontaneous Fractures (Pathological Fracture) 08/2021
1	Starvation 01/2021
1	Brain Diseases (Brain Disorder) 11/2020

Drug/Important Bio-Agent (IBA)

55	Estrogen ReceptorsIBA 03/2024 - 05/2003
25	Estrogens (Estrogen)FDA Link 03/2024 - 09/2003
22	Hormones (Hormone)IBA 12/2023 - 04/2003
21	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2003
14	Estrogen Receptor alphaIBA 03/2024 - 06/2010
12	Cadherins (E-Cadherin)IBA 02/2024 - 09/2003
12	LigandsIBA 12/2023 - 01/2017
11	RNA (Ribonucleic Acid)IBA 03/2024 - 11/2016
10	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 06/2012
9	Aromatase InhibitorsIBA 03/2024 - 04/2013
8	Messenger RNA (mRNA)IBA 03/2024 - 04/2003
8	Biomarkers (Surrogate Marker)IBA 09/2023 - 06/2013
7	Tamoxifen FDA LinkGeneric 09/2023 - 06/2010
6	Phenobarbital (Luminal)FDA Link 09/2023 - 10/2016
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 04/2003
6	Co-Repressor ProteinsIBA 11/2012 - 05/2003
5	Estradiol (Delestrogen)FDA LinkGeneric 09/2023 - 02/2012
5	ChromatinIBA 01/2023 - 02/2010
5	Lysine (L-Lysine)FDA Link 01/2019 - 06/2013
4	Histones (Histone)IBA 01/2023 - 07/2014
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021 - 12/2009
4	Letrozole (Femara)FDA LinkGeneric 09/2017 - 04/2013
4	Insulin-Like Growth Factor I (IGF-1)IBA 02/2012 - 04/2003
3	Fulvestrant (Faslodex)FDA Link 03/2024 - 01/2023
3	SteroidsIBA 01/2021 - 12/2012
3	CarcinogensIBA 01/2020 - 03/2010
3	Insulin-Like PeptidesIBA 10/2018 - 04/2005
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 06/2013
3	Cell-Free Nucleic AcidsIBA 09/2017 - 03/2016
3	exemestane (Aromasin)FDA Link 03/2016 - 04/2013
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2022
2	B7-H1 AntigenIBA 01/2023 - 01/2019
2	ChemokinesIBA 01/2023 - 01/2019
2	Angiotensin IIIBA 03/2022 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2011
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2020
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2021 - 01/2020
2	sulforaphaneIBA 07/2020 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2018 - 06/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 06/2013
2	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2017 - 11/2012
2	Small Interfering RNA (siRNA)IBA 10/2017 - 07/2014
2	ParaffinIBA 01/2017 - 10/2016
2	Formaldehyde (Formol)FDA Link 01/2017 - 10/2016
2	Progestins (Progestagens)IBA 06/2013 - 12/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2023
1	GlucocorticoidsIBA 01/2023
1	ElementsIBA 01/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2023
1	CytokinesIBA 01/2023
1	Thrombin FDA Link 03/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2022
1	ClaudinsIBA 03/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	PlatinumIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Neuropilin-1IBA 01/2022
1	veliparibIBA 01/2022
1	Neuropilin-2IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 10/2021
1	Bone Density Conservation AgentsIBA 08/2021
1	ElectrolytesIBA 08/2021
1	Amino Acids FDA Link 01/2021
1	Waste Products (Waste Product)IBA 01/2021
1	Chitinase-3-Like Protein 1IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Steroid Receptors (Steroid Receptor)IBA 01/2021
1	Peptides (Polypeptides)IBA 11/2020

Therapy/Procedure

49	Therapeutics 03/2024 - 04/2003
7	Immunotherapy 01/2023 - 02/2010
5	Precision Medicine 01/2024 - 03/2017
2	Radiotherapy 08/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 08/2021 - 01/2020
1	Continuity of Patient Care 01/2022
1	Aftercare (After-Treatment) 06/2021